Spectral Medical Inc T.EDT

Spectral's COVID19 Trial a "going concern" - UPDATE SOON?

[SouthernTierTom]

I haven;t had the time to look at the MA&D as of yet, but losing less than 1 penny per share ( .007 ) in these trying times is "admirable" NICE JOB Chris and team Spectral!



I feel like an update on the COVID trial is iminent, given it is still running and OPEN Label

Nice to see Baxter ramping up EAA sales 51% and an 18% overall increase in revenue!

I am kind of surprised by the strength of the Quarter.

Remember that if we use the "correct" patients ( see termianted Euphas phase 2 ) along with Euphas2 registry, and RWD ( real world data, 300,000++ PMX usages ) AND of course the 179 patient from the phase 3 Euphrates....there is a VERY real chance that we never see the final "TIGER(is) tail" patients....The FDA needs this approved as does the world ALL IMHO and I tend to be "optimistic, BUT VERY well educated for a "common shareholder"

Here is the current COVID19 trail status;

• Find Studies
• About Studies
• Submit Studies
• Resources
• About Site
• PRS Login

 

 

• Home
• Search Results
• Study Record Detail

 

 Save this study

 

Trial record 7 of 10 for:    toraymyxin

Previous Study | Return to List | Next Study

Evaluating the Use of Polymyxin B Cartridge Hemoperfusion for Patients With Septic Shock and COVID 19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.